Related content

Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 3, 2014-03 ,pp. : 466-472

Bentham Science Publishers

Access to resources Recommend Favorite

The Sequence-Dependent Cytotoxic Effect of Trastuzumab in Combination With 5-Fluorouracil or Cisplatin on Gastric Cancer Cell Lines

By Li Xiao-Ling   Yi Shao-Qiong   Xu Jian-Ming   Zhang Yang     Chen Wei   Song San-Tai  

Cancer Investigation, Vol. 28, Iss. 10, 2010-11 ,pp. : 1038-1047

Informa Healthcare

Access to resources Recommend Favorite

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

By Kurebayashi Junichi   Nukatsuka Mamoru   Nagase Hideki   Nomura Tsunehisa   Hirono Mai   Yamamoto Yutaka   Sugimoto Yoshikazu   Oka Toshinori   Sonoo Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells

By              

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1171-1176

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells

By            

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1293-1300

Spandidos Publications

Access to resources Recommend Favorite